UPR Uniphar plc
Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company provides sales, marketing, servicing, quality, compliance, regulatory support, and distribution services to medical device manufacturers; high-value services across the life cycle of a pharmaceutical product; and healthcare professionals with access to medicines that cannot source through traditional channels. It is also involved in the pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals and veterinary surgeons; operates a network of pharmacies under the Life, Allcare, Hickey's, and McCauley brands. In addition, the company provides pharmacy support, pharmaceutical supply chain and services, medical device distribution, specialist nursing and infusion, outsourcing and resourcing, healthcare technology, medical affairs, online pharmacy and product fostering, pharmaceutical wholesale distributor, retail pharmacy software and technology, and telecommunications support services, as well as specialist provider of pharmaceuticals. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.…
Industry Peers
Medical DistributionKey Statistics
About Uniphar (ISE: UPR)
›
Uniphar (ISE: UPR) is listed on Euronext Dublin, where its shares trade in EUR. It belongs to the Medical Distribution industry, part of the Healthcare sector, and reports about 3,500 employees.
The shares were at 4.255 EUR on 19 November 2026, up 14.7% over 52 weeks. Its 52-week range is 3.380 EUR to 4.975 EUR: the price is 14.5% below the high and 25.9% above the low.
At a market capitalisation of 1.10B EUR, it trades at 20.3 times trailing earnings and 15.2 times forward earnings. The median trailing P/E of its 17 largest Medical Distribution peers is 23.2, a discount of 13% for UPR. It pays a dividend yielding 0.48% (it pays out 10% of its earnings), against a median of 2.55% among the dividend payers in that peer group.
Uniphar reports return on equity of 12.6%, an operating margin of 2.9% and revenue up 7.2% year over year.
Its debt exceeds its cash by 432.93M EUR, a debt-to-equity ratio of 1.27. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 8 analysts cover the stock; their mean price target of 5.569 EUR is 30.9% above the current price.